CAR T cells at the tumor site were isolated and analyzed by flow cytometry; the data showed that IL15C-NKG2D-CAR T cells expressed higher levels of cytokines CD69, CD107, and GzmB at the tumor site (Figures 6A–C). The gene discussed is CD69; the disease is neoplasm.